Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies.

Kim, Jung-Hyun; Kawase, Eihachiro; Bharti, Kapil; Karnieli, Ohad; Arakawa, Yuji; Stacey, Glyn

Kim, Jung-Hyun; Kawase, Eihachiro; Bharti, Kapil; Karnieli, Ohad; Arakawa, Yuji; Stacey, Glyn.

Afiliação

Kim JH; Korea National Stem Cell Bank, Osong, Korea.
Kawase E; Division of intractable diseases research, Department of chronic diseases convergence research, Korea national institute of health, Osong, Korea.
Bharti K; Division of Clinical Basis for ES Cell Research, Center for Human ES Cell Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8507, Japan.
Karnieli O; Ocular and Stem Cell Translational Research Section, Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
Arakawa Y; Adva Biotechnology, Hadolev3, Bar Lev Industrial Park, Israel.
Stacey G; Facility for iPS cell therapy, CiRA foundation, Kyoto, Japan.

NPJ Regen Med ; 7(1): 54, 2022 Sep 29.

Article em En | MEDLINE | ID: mdl-36175440

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: NPJ Regen Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google